PA8633701A1 - ESTRADIOL PRODUCTS - Google Patents

ESTRADIOL PRODUCTS

Info

Publication number
PA8633701A1
PA8633701A1 PA20058633701A PA8633701A PA8633701A1 PA 8633701 A1 PA8633701 A1 PA 8633701A1 PA 20058633701 A PA20058633701 A PA 20058633701A PA 8633701 A PA8633701 A PA 8633701A PA 8633701 A1 PA8633701 A1 PA 8633701A1
Authority
PA
Panama
Prior art keywords
estradiol
products
estradiol products
strogen
productions
Prior art date
Application number
PA20058633701A
Other languages
Spanish (es)
Inventor
Sven Ring
Ralf Wyrwa
Peter Droescher
Walter Elger
Alexander Hillisch
Gudrun Reddersen
Birgitt Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34969196&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8633701(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of PA8633701A1 publication Critical patent/PA8633701A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PRODROGAS DE ESTRADIOL DE LA FORMULA GENERAL (I), DONDE EL GRUPO Z ESTA UNIDO AL ESTEROIDE, UN PROCEDIMIENTO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y SU USO PARA PREPARAR MEDICAMENTOS CON EFECTO ESTROGENO.ESTRADIOL PRODUCTIONS OF THE GENERAL FORMULA (I), WHERE GROUP Z IS JOINED TO THE STEROID, A PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE TO PREPARE MEDICATIONS WITH STROGEN EFFECT.

PA20058633701A 2004-05-21 2005-05-20 ESTRADIOL PRODUCTS PA8633701A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025966A DE102004025966A1 (en) 2004-05-21 2004-05-21 Estradiol prodrugs

Publications (1)

Publication Number Publication Date
PA8633701A1 true PA8633701A1 (en) 2006-07-03

Family

ID=34969196

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058633701A PA8633701A1 (en) 2004-05-21 2005-05-20 ESTRADIOL PRODUCTS

Country Status (11)

Country Link
EP (1) EP1747230A1 (en)
JP (1) JP2007538025A (en)
AR (1) AR050335A1 (en)
DE (1) DE102004025966A1 (en)
GT (1) GT200500121A (en)
PA (1) PA8633701A1 (en)
PE (1) PE20060359A1 (en)
SV (1) SV2006002121A (en)
TW (1) TW200613315A (en)
UY (1) UY28909A1 (en)
WO (1) WO2005113574A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (en) 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs
DE102005057225A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 8-beta-substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
DE102005057224A1 (en) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag New 9-alpha substituted estratriene derivatives esterified with a sulfamoylphenyl-substituted acid residue, are prodrugs useful as carboanhydrase inhibitors for treating estrogen deficiency disorders
DE102005057408A1 (en) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag New sulfamoylsulfonate prodrugs e.g. useful for protecting red blood cells from attack by parasites or for hormone replacement therapy, female fertility control or treating hormone-associated diseases
MX364743B (en) * 2013-07-11 2019-05-06 Evestra Inc Pro-drug forming compounds.
CN115368427B (en) * 2022-08-17 2024-02-13 南宁师范大学 Estradiol selenocyanate compound and preparation method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1238739A (en) * 1958-08-04 1960-08-19 Chimiotherapie Lab Franc Process for the preparation of water-soluble testosterone derivatives
FR8290M (en) * 1968-12-31 1970-11-09 Rech Chimiques Et Ind Mar Lab
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (en) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroid sulfamates, processes for their preparation and use thereof
WO2001081364A1 (en) * 2000-04-24 2001-11-01 Kyowa Hakko Kogyo Co., Ltd. Estra-1,3,5(10)-triene derivatives
DE10027887A1 (en) * 2000-05-31 2001-12-13 Jenapharm Gmbh Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds
GB0316290D0 (en) * 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
TWI331154B (en) * 2003-11-12 2010-10-01 Solvay Pharm Gmbh Novel 17-hydroxysteroid dehydrogenase type i inhibitors
DE102004025985A1 (en) * 2004-05-21 2005-12-15 Schering Ag Estriol and estetrol prodrugs

Also Published As

Publication number Publication date
DE102004025966A1 (en) 2005-12-15
GT200500121A (en) 2006-01-30
UY28909A1 (en) 2005-12-30
JP2007538025A (en) 2007-12-27
EP1747230A1 (en) 2007-01-31
SV2006002121A (en) 2006-02-15
TW200613315A (en) 2006-05-01
PE20060359A1 (en) 2006-05-25
WO2005113574A1 (en) 2005-12-01
AR050335A1 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
PA8633701A1 (en) ESTRADIOL PRODUCTS
AR027060A1 (en) MANNICH BASES OF 1-NAFTOL AND 2-NAFTOL SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THE USE OF THESE COMPOUNDS FOR THE MANUFACTURE OF MEDICINES
ECSP077316A (en) Substituted bicyclic imidazo-3-yl-amine compounds
ECSP034830A (en) SUBSTITUTED DERIVATIVES OF CICLOHEXANO-1,4- DIAMINE
UY26199A1 (en) NEW BENZENE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
CL2004000969A1 (en) COMPOUNDS DERIVED FROM ALQUILARILO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT AND / OR PROFILAXIS OF OBESITY AND RELATED DISORDERS.
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
ECSP066667A (en) SPIROCICLIC CYCLHEXAN DERIVATIVES
CR10489A (en) PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS
AR025052A1 (en) DERIVATIVES OF 2-DIALQUILAMINOALQUILBIFENILO SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
SV2006002122A (en) ESTRIOL AND ESTETROL PRODUCTS REF. P-SV-78.343 / MSU
SV2006002123A (en) STEROID PROPHARMS WITH ANDROGENIC ACTION REF. P-SV-78.334 / MSU
UY27894A1 (en) CINAMIDE DERIVATIVES
CU23415B7 (en) DERIVATIVES OF 2,6- QUINOLINILO AND 2,6- NAFTILO, PROCESSES FOR THEIR PREPARATION AND ITS USES
UY30356A1 (en) DERIVATIVES OF 3-HALO-N- (2. (4-FLUOROPHENYL) -4-OXOBUTIL) -N-METIL-5- (TRIFLUOROMETIL) BENZAMIDE AND COMPOSITIONS OF THE SAME.
ECSP088472A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCESSES FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
UY27133A1 (en) 11BETA-HALOGENESTEROIDS, ITS OBTAINING AND USE FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL PREPARATIONS CONTAINING 11 BETA-HALOGENESTEROIDS
UY26507A1 (en) SUBSTITUTED 1-NAFTOL AND 2-NAFTOL MANNICH BASES, PROCEDURE FOR THE PREPARATION, MEDICINES CONTAINING THESE COMPOUNDS, AS WELL AS THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
ECSP088481A (en) DRUGS OF ER-BETA-SELECTIVE SUBSTANCES, PROCESSES FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THESE PRODUCTS
PA8629401A1 (en) D-HOMO-17-CHLORINE-16 (17) ENO STEROIDS
UY28846A1 (en) D-HOMO-17-CHLORINE-16 (17) ENO STEROIDS
CL2008000864A1 (en) Pyrimidine derived compounds; pharmaceutical composition comprising said compounds; method of preparation of the pharmaceutical composition; and its use for diseases related to insulin-like growth factor (IGF).
ECSP11011501A (en) 17 -QUENT-17 -OXI-STRATRIENS
ECSP003842A (en) MANNICH BASES OF 1-NAFTOL AND 2-NAFTOL SUBSTITUTED, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS, AS WELL AS THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES.
HN2002000049A (en) NEW TRIAZOLOPIRIDIN ANTI-INFLAMMATORY COMPOUNDS